Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Century Therapeutics Inc (IPSC)

Century Therapeutics Inc (IPSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Century Therapeutics Inc 25 N 38th Street 11th Floor PHILADELPHIA PA 19104 USA

www.centurytx.com P: 267-817-5790

Description:

Century Therapeutics Inc. is a cell therapy company. It involved in developing induced pluripotent stem cell -derived cell therapies in immuno-oncology. Century Therapeutics Inc. is based in PHILADELPHIA.

Key Statistics

Overview:

Market Capitalization, $K 246,056
Enterprise Value, $K 199,376
Shares Outstanding, K 82,847
Annual Sales, $ 2,240 K
Annual Net Income, $ -136,670 K
Last Quarter Sales, $ 860 K
Last Quarter Net Income, $ -28,060 K
EBIT, $ -129,420 K
EBITDA, $ -120,270 K
60-Month Beta 1.44
% of Insider Shareholders 6.80%
% of Institutional Shareholders 50.20%
Float, K 77,213
% Float 93.20%
Short Volume Ratio 0.39

Growth:

1-Year Return -1.98%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.45 on 05/09/24
Next Earnings Date N/A
Earnings Per Share ttm -2.05
EPS Growth vs. Prev Qtr 8.16%
EPS Growth vs. Prev Year 15.09%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

IPSC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -59.74%
Return-on-Assets % -32.52%
Profit Margin % -6,101.34%
Debt/Equity 0.00
Price/Sales 114.17
Price/Cash Flow N/A
Price/Book 1.12
Book Value/Share 2.74
Interest Coverage -248.61
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar